The 7th International Symposium on Hepatitis Care in Substance Users (INHSU 2018) is to be held at Hotel Cascais Miragem, Cascais, Portugal, 19 – 21 September 2018. For the first time, the symposium is being developed by four co-convenors; Dr. Ricardo Baptiste Leite, Prof. Jeffrey Lazarus, Prof. Rui Tato Marinho and Luís Mendão bringing together […]
World Hepatitis Day takes place every year on 28 July, with the aim of bringing the world together under one single theme in order to raise awareness of viral hepatitis and the impact it has worldwide. The theme for World Hepatitis Day 2018 is “Eliminate Hepatitis”. Hepatitis B virus and hepatitis C virus are the […]
Media Release: 9 March 2018 The inclusion of the recommendation to introduce a needle and syringe program (NSP) within Canberra’s prison in the ACT Health Service Commissioner’s review of the opioid replacement treatment program at the Alexander Maconochie Centre (AMC) released today has been welcomed by Hepatitis ACT. “This review continues to build the picture […]
Despite new 95% curative treatments being listed on the Pharmaceutical Benefits Scheme (PBS) at a huge cost to the taxpayer, the provision of treatment is failing to connect with hundreds of thousands of Australians living with hepatitis C. This means the Government is at risk of missing its target to eradicate hepatitis C by 2030 […]
Media Release: 3 February 2018 Shine a Spotlight on Liver Disease for World Cancer Day On Sunday 4 February 2018 – World Cancer Day – Hepatitis ACT joins with thousands of organisations globally and locally in highlighting the devastating impact cancer can have on individuals, families and communities across the world. Hepatitis ACT Executive Officer […]
Following 27 confirmed hepatitis A cases in 9 months affecting men who have sex with men (MSM) (and to a lesser extent people who inject drugs) in Victoria, and a further 13 cases in South Australia since November 2017, senior public health officials in those states have issued advice promoting hepatitis A vaccinations. There have […]
Concerning reports are circulating about a government data bungle potentially exposing ten percent of private health records. Researchers from the University of Melbourne have reportedly been able to establish the identity of patients from confidential data published by the Commonwealth Department of Health. Seemingly this includes MBS and PBS claims data, and is of concern […]
HEPATITIS AUSTRALIA Media Release 6 November 2017 The number of Australians living with hepatitis C and advanced liver disease has fallen for the first time in ten years but elimination of the virus remains uncertain, according to campaigners. Published today, the Kirby Institute’s latest Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible Infections […]
Researchers at the University of NSW are investigating the impact of family support in dealing with viral hepatitis. They are looking to recruit people with lived experience of hepatitis B or hepatitis C as well as their family support network, to be interviewed face to face, for the My Health, Our Family research project. “We […]
Hepatitis ACT congratulates the 18 hepatitis C change makers recognised for their innovative, replicable, scalable, feasible and meaningful impacts in hepatitis C elimination. In particular we acknowledge the three Australian recipients: Helen Tyrrell (Hepatitis Australia), Melanie Eagle (Hepatitis Victoria) and Professor Greg Dore (UNSW; St Vincent’s Hospital). The Economist Intelligence Unit HCV C Change Makers […]